August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? – Oncogene Cancer Research
Aug 18, 2025, 16:46

How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? – Oncogene Cancer Research

Oncogene Cancer Research shared a post on X:

“How do we select the best 2L therapy for advanced EGFR‑mutant NSCLC after osimertinib?

Dr. Julia Rotow outlines options by resistance mechanism, including the emerging amivantamab + lazertinib combo. Personalized strategies matter.”

Read Further.

More posts featuring Oncogene Cancer Research.